☰

Jana K. Shirey-Rice, Ph.D. - Publications

Institution:
Vanderbilt University, Nashville, TN
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Jerome RN, Joly MM, Kennedy N, Shirey-Rice JK, Roden DM, Bernard GR, Holroyd KJ, Denny JC, Pulley JM. Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use. Drug Safety. PMID 32112228 DOI: 10.1007/S40264-020-00915-6  0.329
2019 Pulley JM, Rhoads JP, Jerome RN, Challa AP, Erreger KB, Joly MM, Lavieri RR, Perry KE, Zaleski NM, Shirey-Rice JK, Aronoff DM. Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data. Annual Review of Pharmacology and Toxicology. PMID 31337270 DOI: 10.1146/Annurev-Pharmtox-010919-023537  0.347
2018 Jerome RN, Pulley JM, Roden DM, Shirey-Rice JK, Bastarache LA, Bernard G, Ekstrom L, Lancaster WJ, Denny JC. Reply to Ward and Colleagues' Comment on "Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors". Drug Safety. PMID 30066313 DOI: 10.1007/S40264-018-0701-Z  0.308
2017 Pulley JM, Jerome RN, Zaleski NM, Shirey-Rice JK, Pruijssers AJ, Lavieri RR, Chettiar SN, Naylor HM, Aronoff DM, Edwards DA, Niswender CM, Dugan LL, Crofford LJ, Bernard GR, Holroyd KJ. When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data. Assay and Drug Development Technologies. 15: 354-361. PMID 29193979 DOI: 10.1089/Adt.2017.821  0.321
2017 Jerome RN, Pulley JM, Roden DM, Shirey-Rice JK, Bastarache LA, R Bernard G, B Ekstrom L, Lancaster WJ, Denny JC. Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors. Drug Safety. PMID 29185237 DOI: 10.1007/S40264-017-0616-0  0.341
2017 Pulley JM, Shirey-Rice JK, Lavieri RR, Jerome RN, Zaleski NM, Aronoff DM, Bastarache L, Niu X, Holroyd KJ, Roden DM, Skaar EP, Niswender CM, Marnett LJ, Lindsley CW, Ekstrom LB, et al. Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics. Assay and Drug Development Technologies. PMID 28379727 DOI: 10.1089/Adt.2016.772  0.365
2015 Giltnane JM, Shirey-Rice J, Linder J, Bowton E, Cowan J, Wang X, Scherdin J, Basford M, Dahlman K, Roland J, Wiles K, Vnencak-Jones C, Washington K, Pulley J. Abstract 222: PathLink: Leveraging clinical informatics to empower translational pathology by connecting biospecimens to outcomes Cancer Research. 75: 222-222. DOI: 10.1158/1538-7445.Am2015-222  0.303
Show low-probability matches.